NCT05130099Completed
A Complex Intervention for Chronically Fatigued Lymphoma Survivors
A Complex Intervention for a Complex Symptom - a Randomized Controlled Trial in Chronically Fatigued Lymphoma Survivors
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
The present study is a randomized controlled trial (RCT) with an overall objective to examine the effect of an interdisciplinary complex intervention on the level of fatigue in lymphoma survivors with chronic fatigue. Secondary aims are to examine the effects of the intervention on daily functioning, work status/ability, physical fitness and QoL among the survivors, on QoL of their relatives and on the societal costs.The intervention will last for 12+12 weeks and include four components; patient education, supervised physical exercise, cognitive behavioral program and nutritional counselling. Outcomes will be assessed at baseline,post-intervention (12 weeks after baseline) and at 3-month, 6-month, 12-month and 24-month follow-up after completed intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 10 Nov 2021
- Start date
- 20 Nov 2021
- Primary completion date
- 30 Jun 2023
- Lead sponsor
- Oslo University Hospital
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05130099
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 20 Nov 2021 to the primary completion date, 30 Jun 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Persisting fatigue > 1 year before the cancer diagnosis
- Somatic/physical conditions (i.e. severe heart failure/disease, lung disease, use of wheelchair /crutches)
- Psychiatric or mental disorders (i.e. dementia, severe depression, schizophrenia)
- Substance abuse disorder
Other
- Use of stimulants for ADHD
Who the study is looking for
- Survivors of Hodgkin and aggressive non-Hodgkin lymphoma
- Not indolent non-Hodgkin lymphoma
- Not CNS lymphoma at diagnosis
- Not second cancer
- Not ongoing cancer treatment
- Chronic fatigue measured by Chalder Fatigue Questionnaire
- Diagnosed 2010-2020
- Received treatment with curative intent
- 18 - 70 years old at inclusion
- > 2 years since last treatment
- Able to understand the Norwegian language
- Participation approval from oncologist in the project group
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital | Oslo | Norway | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.